Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Tirzepatide, glycine, and B12 The most widely prescribed compounded formulation during periods of shortage availability
It produces greater weight loss (approximately 10-12% even in diabetic patients, who typically lose less than non-diabetics), provides excellent blood sugar control (HbA1c reductions of 1.0-1.8 percentage points), and has proven cardiovascular protection (especially important since diabetes increases cardiovascular risk)
As of right now, oral tirzepatide is not covered by insurance.
NSL literature pointer PMID 10379149 L-Carnitine laboratory index [PMID: 10379149] National Science Labs indexing note for PMID 10379149: review the PubMed methods, models, and limitations before citing
We are a professional peptide manufacturer with advanced equipment, large-scale laboratories, and strict quality control ensuring consistent and reliable production How is the product shipped
